Medtronic plans to initiate a limited market release in the US, starting with existing standalone CGM and InPen customers ...

The approval of Simplera CGM aligns with Medtronic’s strategy to integrate this device with other smart multiple daily injection (MDI) tools, such as the InPen smart insulin pen and the Simplera ...

Medtronic disclosed that the Food and Drug Administration ... is designed to be used as part of a Smart MDI system with the InPen smart insulin pen and Simplera Sync sensor. Medtronic also ...

The recent FDA approval for Simplera™ CGM lays the groundwork for future submission of the updated InPen™ smart insulin pen app, which would facilitate integration with Simplera™ CGM, as a Smart MDI ...

Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price stagnation since 2018. Despite recent improvements in performance, Medtronic ...

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year. More favorable market conditions could lead to ...

Shares of Medtronic PLC climbed toward a three-month high in early Tuesday trading, after the medical-technology company topped fiscal first-quarter earnings expectations, amid strength in its ...

Medtronic (MDT) is a billion-dollar global leader in medical technology, offering medical devices and therapies to more than 74 million people across 150+ countries. Medtronic—derived from ...

The MiniMed™ 780G system is Medtronic’s most advanced insulin delivery system ... The Simplera™ CGM for integrated use with the InPen™ smart insulin pen received CE Mark in September 2023. References ...

Medical device giant Medtronic (NYSE: MDT) has been somewhat of a stock market laggard over the past five years, partly due to pandemic-related disruptions. Even beyond this global issue ...

Aug 20 (Reuters) - Medtronic (MDT.N), opens new tab slightly lifted the lower end of its annual profit forecast on Tuesday, banking on sustained demand for its medical devices and growth from its ...